GIL

A securities class action lawsuit has been filed against Gildan Activewear for investors who purchased securities between February 19, 2025 and June 15, 2026. The lawsuit alleges that Gildan engaged in channel stuffing and lacked adequate internal controls to artificially inflate revenues.

The allegations emerged after Jehoshaphat Research published a report on June 16, 2026, causing Gildan's stock to plummet 18.7%. The deadline to move the court to become lead plaintiff is December 14, 2026.

Rosen Law Firm has filed a class action lawsuit against Gildan Activewear Inc. on behalf of investors who purchased securities between February 19, 2025 and June 15, 2026. The lawsuit alleges that Gildan made false and misleading statements regarding its business operations, failed to disclose inadequate internal controls, and engaged in channel stuffing to artificially inflate revenue. Investors who wish to serve as lead plaintiff must file by December 14, 2026.

Rosen Law Firm has filed a class action lawsuit against Gildan Activewear Inc. on behalf of investors who purchased securities between February 19, 2025 and June 15, 2026. The lawsuit alleges that Gildan made false and misleading statements regarding its business operations, failed to disclose inadequate internal controls, and engaged in channel stuffing to artificially inflate revenue. Investors who wish to serve as lead plaintiff must file by December 14, 2026.

Gildan Activewear raised its 2026 adjusted EPS guidance to $4.65-$4.75 and free cash flow outlook to $1 billion, driven by faster-than-expected HanesBrands integration synergies ($100 million) and $220 million in tariff refunds. However, soft retail demand and $4.7 billion in net debt remain headwinds. The company targets a 21.8% operating margin for 2026.

Gildan Activewear (GIL) shares declined 11.1% in four weeks as weak retail demand and HanesBrands integration execution risks weigh on investor sentiment. Despite raising 2026 adjusted EPS guidance to $4.65-$4.75 and operating margin forecast to 21.8%, the company's $4.7 billion net debt and 3.2X leverage remain concerns. The stock trades at a discount valuation but faces headwinds from retail softness and elevated acquisition-related costs.

Gildan Activewear (GIL) has fallen 22.7% in 12 weeks and trades at a steep valuation discount of 8.0X forward earnings versus the industry's 15.3X. While the HanesBrands integration promises $100 million in 2026 synergies and earnings growth to $4.67 per share, the company faces significant headwinds including $4.7 billion in net debt, elevated leverage, and soft retail demand. The stock's upside potential depends on successful execution of integration targets and debt reduction, but current risks favor a cautious stance.

Rosen Law Firm is investigating potential securities claims against Gildan Activewear Inc. following a short seller report by Jehoshaphat Research that alleged the company engaged in financial engineering to obscure negative organic growth. Gildan's stock fell 18.7% on June 16, 2026, after the report was published. The firm is preparing a class action lawsuit to recover investor losses.

The Rosen Law Firm is investigating potential securities claims against Gildan Activewear Inc. following a short seller report by Jehoshaphat Research that alleged the company engaged in financial engineering to obscure negative organic growth. Gildan's stock fell 18.7% on June 16, 2026, after the report questioned the company's organic growth and sales practices. The firm is preparing a class action lawsuit to recover investor losses.

The Rosen Law Firm is investigating potential securities claims against Gildan Activewear Inc. after a short seller report from Jehoshaphat Research alleged the company engaged in financial engineering to obscure negative organic growth. The stock fell 18.7% on June 16, 2026, following the report's release. Investors who suffered losses are encouraged to join a prospective class action lawsuit.

The Rosen Law Firm is investigating potential securities claims against Gildan Activewear Inc. following a short seller report by Jehoshaphat Research that alleged the company's organic growth has been negative for years despite appearing to show revenue growth through financial engineering. Gildan's stock fell 18.7% on June 16, 2026, following the report's release. The firm is preparing a class action lawsuit to recover investor losses.

Somnigroup International Inc. (SGI) maintains a strong position in the global mattress and bedding industry through its portfolio of premium brands including Tempur-Pedic, Sealy, and Stearns & Foster. The company focuses on product innovation, operational efficiency, and diversified distribution channels.

SGI trades at a forward P/E of 16.45X, below the industry average of 17.29X, with consensus estimates showing 15.2% EPS growth in 2026 and 28.5% in 2027. The stock has declined 19.7% in the past six months but carries a Zacks Rank #1 (Strong Buy) rating.

NIKE shares declined 2.2% after reporting Q1 fiscal 2027 earnings that beat expectations but showed a 4% revenue decline. Greater China sales plunged 22% and weakness in Sportswear and Jordan Brand offset gains in performance categories. The company expects fiscal 2027 revenues to fall at a high-single-digit rate despite $2.5B in planned Pace savings, with analysts downgrading earnings estimates significantly.

NIKE beat EPS estimates at 48 cents but reported a 4.3% revenue decline to $11.2 billion, missing consensus. The company faces weakness in Sportswear, Jordan Brand, and Greater China, with Direct channel revenues down 8%. Management projects high-single-digit fiscal 2027 revenue declines and introduced the Pace restructuring program targeting $2.5 billion in savings through 2031.

Rosen Law Firm has filed class action lawsuits against Qfin Holdings, Inc. for allegedly making false and misleading statements about business resilience and downplaying regulatory impacts during the Class Period (March 18, 2026 - August 25, 2026). Investors who purchased securities during this period may be eligible for compensation. The deadline to serve as lead plaintiff is November 30, 2026.